Naomi Runnegar
Overview
Explore the profile of Naomi Runnegar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
569
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schults J, Havers S, Henderson B, Healy S, Runnegar N, Hurst T, et al.
Am J Infect Control
. 2025 Mar;
PMID: 40049373
Background: Healthcare-associated infections (HAIs) continue to contribute significantly to Australia's burden of disease. In Queensland, varied surveillance protocols exist contributing to unnecessary complexity. With end-user partners, we defined a minimum...
2.
Ullman A, August D, Kleidon T, Walker R, Marsh N, Bulmer A, et al.
N Engl J Med
. 2025 Jan;
392(2):161-172.
PMID: 39778170
Background: New catheter materials for peripherally inserted central catheters (PICCs) may reduce the risk of device failure due to infectious, thrombotic, and catheter occlusion events. However, data from randomized trials...
3.
Corley A, Royle R, Marsh N, Larsen E, Playford E, McGrail M, et al.
J Hosp Med
. 2024 May;
19(10):905-917.
PMID: 38800854
Background: Central venous access devices (CVADs) allow intravenous therapy, haemodynamic monitoring and blood sampling but many fail before therapy completion. Objective: To quantify CVAD failure and complications; and identify risk...
4.
Grey V, Simos P, Runnegar N, Eisemann J
Access Microbiol
. 2023 Dec;
5(11).
PMID: 38074103
Diagnosis of chronic Q fever is often difficult for clinicians, particularly in the presence of a second pathology. In addition to the chronic constitutional symptoms, the most common manifestations of...
5.
Cho Y, Chow K, Kam-Tao Li P, Runnegar N, Johnson D
Clin J Am Soc Nephrol
. 2023 Aug;
19(5):641-649.
PMID: 37574658
Peritoneal dialysis (PD) represents an important treatment choice for patients with kidney failure. It allows them to dialyze outside the hospital setting, facilitating enhanced opportunities to participate in life-related activities,...
6.
Hall V, Sim B, Lim C, Hocking C, Teo T, Runnegar N, et al.
Lancet Reg Health West Pac
. 2023 Jun;
:100824.
PMID: 37360862
Background: The global COVID-19 pandemic disproportionately affected certain populations and its management differed between countries. This national study describes characteristics and outcomes of COVID-19 in patients with cancer in Australia....
7.
Chow K, Runnegar N, So S, Cho Y, Johnson D, Kam-Tao Li P
Perit Dial Int
. 2023 Jun;
43(3):276-278.
PMID: 37303130
No abstract available.
8.
Gavin N, Larsen E, Runnegar N, Mihala G, Keogh S, McMillan D, et al.
JPEN J Parenter Enteral Nutr
. 2023 Jun;
47(6):783-795.
PMID: 37288612
Background: Distinguishing primary bloodstream infections (BSIs) related to central venous access devices (CVADs) from those that occur through other mechanisms, such as a damaged mucosal barrier, is difficult. Methods: Secondary...
9.
Chow K, Kam-Tao Li P, Cho Y, Abu-Alfa A, Bavanandan S, Brown E, et al.
Perit Dial Int
. 2023 May;
43(3):201-219.
PMID: 37232412
Peritoneal dialysis (PD) catheter-related infections are important risk factors for catheter loss and peritonitis. The 2023 updated recommendations have revised and clarified definitions and classifications of exit site infection and...
10.
Permana B, Harris P, Runnegar N, Lindsay M, Henderson B, Playford E, et al.
Microbiol Spectr
. 2023 May;
11(3):e0420422.
PMID: 37191518
To investigate an outbreak of vancomycin-resistant Enterococcus faecium (VREfm) sequence type 78 (ST78) in a large tertiary Australian hospital. A collection of 63 VREfm ST78 isolates, identified during a routine...